Abstract
Patients with chronic kidney disease are usually recommended to undertake changes in their diet and lifestyle as part of their overall management strategy. Indeed, most patients believe that changes in their diet and lifestyle are among the most important interventions for the management of their kidney disease. Most familiar are the restrictions in protein intake to slow renal progression and reducing the intake of potassium to prevent hyperkalaemia. However, the effects of both appear modest at best and not clearly associated with improved patient outcomes. While interventions such as weight loss, sodium restriction and increased physical activity are clearly beneficial in patients at risk of cardiovascular disease, their utility specifically in patients with chronic kidney disease also remains to be established. Moreover, the risk of adverse outcomes may be increased including vascular events, hyperkalaemia, malnutrition and activation of pathways that promote progressive renal damage. At the same time, restrictions imposed by adherence may be associated with a reduced quality of life in precisely those patients who have the worst life expectancy. This chapter reviews the key opportunities for diet and lifestyle interventions in patients with chronic kidney disease, considering both their potential benefits and risks and the possibilities for careful tailoring interventions to individual patient’s needs and values.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev. 2007;(4):CD002181.
Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002;62:220–8.
Kitazato H, Fujita H, Shimotomai T, Kagaya E, Narita T, Kakei M, Ito S. Effects of chronic intake of vegetable protein added to animal or fish protein on renal hemodynamics. Nephron. 2002;90:31–6.
Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, Kotanko P, Pitt B, Saran R. Serum potassium and outcomes in ckd: insights from the rri-ckd cohort study. Clin J Am Soc Nephrol. 2010;5:762–9.
Ryu S, Chang Y, Woo HY, Kim SG, Kim DI, Kim WS, Suh BS, Choi NK, Lee JT. Changes in body weight predict ckd in healthy men. J Am Soc Nephrol. 2008;19:1798–805.
Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, Gansevoort RT. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant. 2007;22:1619–27.
Cardenas C, Bordiu E, Bagazgoitia J, Calle-Pascual AL, Diabetes, Nutrition Study Group SDA. Polyunsaturated fatty acid consumption may play a role in the onset and regression of microalbuminuria in well-controlled type 1 and type 2 diabetic people: a 7-year, prospective, population-based, observational multicenter study. Diabetes Care. 2004;27:1454–7.
Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH, FinnDiane Study G. The association between dietary sodium intake, esrd, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34:861–6.
Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD, Group HONS. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011;343:d4366.
Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, Campbell D, Nicholls K, Tong A, Mangos G, Stack A, MacIsaac RJ, Girgis S, Colagiuri R, Colagiuri S, Craig J, CARI. The cari guidelines. Prevention and management of chronic kidney disease in type 2 diabetes. Nephrol. 2010;15 Suppl 1:S162–94.
Cecchin E, De Marchi S. Alcohol misuse and renal damage. Addict Biol. 1996;1:7–17.
Klarlund M, Prieme H, Loft S, Enghusen PH. Smoking cessation does not change urinary albumin excretion in normal subjects. Scand J Clin Lab Invest. 1997;57:513–20.
Voulgari C, Katsilambros N, Tentolouris N. Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study. Metabolism. 2011;60:1456–64.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3(Suppl):1–150. http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thomas, M.C. (2014). Preventing Progression of Chronic Kidney Disease: Diet and Lifestyle. In: Arici, M. (eds) Management of Chronic Kidney Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54637-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-54637-2_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54636-5
Online ISBN: 978-3-642-54637-2
eBook Packages: MedicineMedicine (R0)